[Initial treatment for uterine cervical neoplasms].
Takeshima
Nobuhiro
N
Department of Gynecology, Cancer Institute Hospital, Ariake 3-10-6, Koutou-ku, Tokyo, Japan
Takizawa
Ken
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D012307:Risk Factors; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
D000970:Antineoplastic Agents